Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$599.78 USD
-12.10 (-1.98%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $600.02 +0.24 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Company Summary
Headquartered in Waltham, MA, Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation.
In terms of end market served, there are four divisions-- pharmaceutical and biotech, academic and government, industrial and applied, and healthcare and diagnostics.
Following the acquisition, the new reporting segments are:
Life Sciences ...
Company Summary
Headquartered in Waltham, MA, Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation.
In terms of end market served, there are four divisions-- pharmaceutical and biotech, academic and government, industrial and applied, and healthcare and diagnostics.
Following the acquisition, the new reporting segments are:
Life Sciences Solutions Segment representing 23.3% of total revenues in 2023, was added post the acquisition of Life Technologies. It incorporates majority of the former Life Technologies and Thermo Fisher’s Biosciences businesses. In 2023, this business registered fall of 26.3% from 2022.
In July 2024, Thermo Fisher acquired Olink, a provider of next-generation proteomics solutions.
Analytical Instruments (formerly known as Analytical Technology) segment represents 16.9% of total revenues in 2023 has been renamed in order to reflect the transfer of the bioprocess production business to the newly formed Life Sciences Solutions Segment. In 2023, this business registered growth of 9.6% from 2022.
Specialty Diagnostics (SD) segment represents 10.3% of total revenues, formed after the acquisition of Phadia, serves customers in healthcare and clinical laboratories with a portfolio of diagnostic test kits, reagents and instruments used to increase the speed and accuracy of diagnoses to improve patient care. In 2023, this business registered a growth of 7.5% from 2022.
Laboratory Products and Biopharma Services (formerly known as Laboratory Products and Services), segment represents 53.8% of total revenues. It has been renamed to reflect the inclusion of the PPD acquisition. PPD has been referred to as a clinical research business within this segment. In 2023, this business registered growth of 2.4% from 2022.
General Information
Thermo Fisher Scientific Inc
168 Third Avenue
Waltham, MA 02451
Phone: 781-622-1000
Fax: 781-622-1207
Web: http://www.thermofisher.com
Email: investorrelations@thermofisher.com
Industry | Medical - Instruments |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 10/23/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 5.25 |
Current Year EPS Consensus Estimate | 21.72 |
Estimated Long-Term EPS Growth Rate | 7.30 |
Exp Earnings Date | 10/23/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 611.88 |
52 Week High | 627.88 |
52 Week Low | 415.60 |
Beta | 0.78 |
20 Day Moving Average | 1,205,760.25 |
Target Price Consensus | 654.10 |
4 Week | 0.24 |
12 Week | 14.60 |
YTD | 15.28 |
4 Week | -1.63 |
12 Week | 10.12 |
YTD | -4.09 |
Shares Outstanding (millions) | 382.00 |
Market Capitalization (millions) | 233,735.44 |
Short Ratio | NA |
Last Split Date | 6/6/1996 |
Dividend Yield | 0.25% |
Annual Dividend | $1.56 |
Payout Ratio | 0.07 |
Change in Payout Ratio | 0.01 |
Last Dividend Payout / Amount | 9/13/2024 / $0.39 |
Fundamental Ratios
P/E (F1) | 28.17 |
Trailing 12 Months | 28.02 |
PEG Ratio | 3.88 |
vs. Previous Year | 4.27% |
vs. Previous Quarter | 5.09% |
vs. Previous Year | -1.37% |
vs. Previous Quarter | 1.89% |
Price/Book | 4.93 |
Price/Cash Flow | 20.09 |
Price / Sales | 5.52 |
6/30/24 | 18.22 |
3/31/24 | 18.45 |
12/31/23 | 18.78 |
6/30/24 | 8.61 |
3/31/24 | 8.65 |
12/31/23 | 8.70 |
6/30/24 | 1.72 |
3/31/24 | 1.70 |
12/31/23 | 1.75 |
6/30/24 | 1.37 |
3/31/24 | 1.33 |
12/31/23 | 1.39 |
6/30/24 | 19.90 |
3/31/24 | 19.69 |
12/31/23 | 19.52 |
6/30/24 | 14.69 |
3/31/24 | 14.20 |
12/31/23 | 13.99 |
6/30/24 | 16.20 |
3/31/24 | 15.35 |
12/31/23 | 14.69 |
6/30/24 | 124.14 |
3/31/24 | 119.21 |
12/31/23 | 120.93 |
6/30/24 | 4.82 |
3/31/24 | 4.76 |
12/31/23 | 4.72 |
6/30/24 | 0.64 |
3/31/24 | 0.68 |
12/31/23 | 0.67 |
6/30/24 | 39.06 |
3/31/24 | 40.74 |
12/31/23 | 40.21 |